Literature DB >> 3874522

A standardized human T-lymphocyte proliferation assay for detecting soluble accessory factors from monocytes. II. Interleukin-1 production and detection.

L Remvig, C Enk, M Svenson.   

Abstract

Conditions for production and detection of a monocyte-derived interleukin-1 like accessory factor were investigated. The production of the accessory factor was not increased quantitatively by changes in monocyte concentration or incubation times. Lipopolysaccharides stimulated monocytes to accessory factor production in a broad range of concentrations, and it was active even in concentrations below the often registered endotoxin contamination of commercial culture media. Thus, to avoid unintended monocyte stimulation culture conditions should be endotoxin-free. The accessory factor was heat-labile, had a MW between 10 and 40 K, was co-mitogenic to PHA-stimulated monocyte depleted cells and it did not support the growth of an interleukin-2 dependent cell-line. Thus the factor shares characteristics with and might be identical to interleukin-1. The conditions previously defined for the demonstration of accessory effect of monocytes were also optimal for demonstration of interleukin-1 in supernatants from lipopolysaccharide stimulated monocyte cultures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874522     DOI: 10.1111/j.1699-0463.1985.tb02928.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  2 in total

1.  Interleukin-1 alpha gene-transcription in murine keratinocytes is inhibited by HSV-1 infection.

Authors:  C Enk; E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Epidermis and lymphocyte interactions during a tuberculin skin reaction. I. Increased ETAF/IL-1 like activity, expression of tissue antigens and mixed skin lymphocyte reactivity.

Authors:  C G Larsen; T Ternowitz; F G Larsen; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.